Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
43,853,865
-
Share change
-
+264,205
-
Total reported value
-
$84,634,096
-
Put/Call ratio
-
24%
-
Price per share
-
$1.93
-
Number of holders
-
66
-
Value change
-
-$1,404,030
-
Number of buys
-
30
-
Number of sells
-
27
Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) as of Q4 2020
As of 31 Dec 2020,
SOLENO THERAPEUTICS INC - COM NEW (SLNO) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,853,865 shares.
The largest 10 holders included
Abingworth LLP, Nantahala Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, ORACLE INVESTMENT MANAGEMENT INC, BlackRock Inc., Granite Point Capital Management, L.P., VANGUARD GROUP INC, CVI Holdings, LLC, AWM Investment Company, Inc., and STATE STREET CORP.
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.